Furthermore, compounds that enhance LEP signaling have been shown to reduce neuronal apoptosis in the substantia nigra in a rat model of PD induced by 6-hydroxydopamine, suggesting therapeutic potential through targeting LEP-mediated inflammatory regulation. The gene discussed is LEP; the disease is Parkinson disease.